Life Sciences BPO Market, By Service Type (CMO (API Manufacturing, Final dosage form manufacturing, Packaging), CRO (Drug Discovery, Preclinical studies, Early Phase I - IIa, Phase IIa - III, Phase IIIb - IV, Medical writing, Pharmcovigilance, Monitoring,

Life Sciences BPO Market, By Service Type (CMO (API Manufacturing, Final dosage form manufacturing, Packaging), CRO (Drug Discovery, Preclinical studies, Early Phase I - IIa, Phase IIa - III, Phase IIIb - IV, Medical writing, Pharmcovigilance, Monitoring, Clinical Data Management, Regulatory services, Bio-statistics, Site management, Protocol development), Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Life Sciences BPO market comprises of contracting of non-primary business activities and functions to a third-party provider. The global life sciences BPO market is driven by factors such as increasing cost of research and development (R&D), growing price pressures, and increase in investments by pharmaceutical and medical devices companies in emerging economies such as India, China, Brazil, and South Africa. Furthermore, increasing prevalence of Covid-19 and subsequent R&D activities is also expected to propel growth of the global life sciences BPO market over the forecast period.
Key features of the study:
This report provides in-depth analysis of the Global Life Sciences BPO market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the Global Life Sciences BPO market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Accenture, Plc., Boehringer Ingelheim GmbH, Charles River Laboratories International, Inc., Cognizant Technology Solutions, Covance, Inc., DSM, Fareva, ICON, Plc, Infosys, Catalent, Inc., Genpact Limited, Health Decisions, Inc., and ProMab Biotechnologies, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The Global Life Sciences BPO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Life Sciences BPO market
Detailed Segmentation:
Global Life Sciences BPO Market, By Service Type:
CMO
API Manufacturing
Final dosage form manufacturing
Packaging
CRO
Drug Discovery
Preclinical studies
Early Phase I - IIa
Phase IIa - III
Phase IIIb - IV
Medical writing
Pharmcovigilance
Monitoring
Clinical Data Management
Regulatory services
Bio-statistics
Site management
Protocol development
Others
Global Life Sciences BPO Market, By Region:
North America
By Service Type:
CMO
API Manufacturing
Final dosage form manufacturing
Packaging
CRO
Drug Discovery
Preclinical studies
Early Phase I - IIa
Phase IIa - III
Phase IIIb - IV
Medical writing
Pharmcovigilance
Monitoring
Clinical Data Management
Regulatory services
Bio-statistics
Site management
Protocol development
Others
By Country
U.S.
Canada
Latin America
By Service Type:
CMO
API Manufacturing
Final dosage form manufacturing
Packaging
CRO
Drug Discovery
Preclinical studies
Early Phase I - IIa
Phase IIa - III
Phase IIIb - IV
Medical writing
Pharmcovigilance
Monitoring
Clinical Data Management
Regulatory services
Bio-statistics
Site management
Protocol development
Others
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Service Type:
CMO
API Manufacturing
Final dosage form manufacturing
Packaging
CRO
Drug Discovery
Preclinical studies
Early Phase I - IIa
Phase IIa - III
Phase IIIb - IV
Medical writing
Pharmcovigilance
Monitoring
Clinical Data Management
Regulatory services
Bio-statistics
Site management
Protocol development
Others
By Country
U.K.
Germany
France
Spain
Italy
Russia
Rest of Europe
Asia Pacific
By Service Type:
CMO
API Manufacturing
Final dosage form manufacturing
Packaging
CRO
Drug Discovery
Preclinical studies
Early Phase I - IIa
Phase IIa - III
Phase IIIb - IV
Medical writing
Pharmcovigilance
Monitoring
Clinical Data Management
Regulatory services
Bio-statistics
Site management
Protocol development
Others
By Country
China
Japan
India
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Service Type:
CMO
API Manufacturing
Final dosage form manufacturing
Packaging
CRO
Drug Discovery
Preclinical studies
Early Phase I - IIa
Phase IIa - III
Phase IIIb - IV
Medical writing
Pharmcovigilance
Monitoring
Clinical Data Management
Regulatory services
Bio-statistics
Site management
Protocol development
Others
By Country
GCC Countries
Israel
Rest of Middle East
Africa
By Service Type:
CMO
API Manufacturing
Final dosage form manufacturing
Packaging
CRO
Drug Discovery
Preclinical studies
Early Phase I - IIa
Phase IIa - III
Phase IIIb - IV
Medical writing
Pharmcovigilance
Monitoring
Clinical Data Management
Regulatory services
Bio-statistics
Site management
Protocol development
Others
By Country
North Africa
Central Africa
South Africa
Company Profiles
Accenture, Plc. *
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
Boehringer Ingelheim GmbH
Charles River Laboratories International, Inc.
Cognizant Technology Solutions
Covance, Inc.
DSM
Fareva
ICON, Plc
Infosys
Catalent, Inc.
Genpact Limited
Health Decisions, Inc.
Health Decisions, Inc.
“*” marked represents similar segmentation in other categories in the respective section.